These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 8549381)
1. Experimental and clinical studies of sparfloxacin in Mycoplasma pneumoniae infection. Kaku M; Ishida K; Kohno S; Koga H; Hara K; Usui T Drugs; 1995; 49 Suppl 2():412-3. PubMed ID: 8549381 [No Abstract] [Full Text] [Related]
2. In vitro and in vivo activities of sparfloxacin against Mycoplasma pneumoniae. Kaku M; Ishida K; Irifune K; Mizukane R; Takemura H; Yoshida R; Tanaka H; Usui T; Tomono K; Suyama N Antimicrob Agents Chemother; 1994 Apr; 38(4):738-41. PubMed ID: 8031039 [TBL] [Abstract][Full Text] [Related]
3. In vitro and in vivo activities of Q-35, a new fluoroquinolone, against Mycoplasma pneumoniae. Gohara Y; Arai S; Akashi A; Kuwano K; Tseng CC; Matsubara S; Matumoto M; Furudera T Antimicrob Agents Chemother; 1993 Sep; 37(9):1826-30. PubMed ID: 8239590 [TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo efficacies of T-3811ME (BMS-284756) against Mycoplasma pneumoniae. Takahata M; Shimakura M; Hori R; Kizawa K; Todo Y; Minami S; Watanabe Y; Narita H Antimicrob Agents Chemother; 2001 Jan; 45(1):312-5. PubMed ID: 11120986 [TBL] [Abstract][Full Text] [Related]
5. Effects of new quinolones on Mycoplasma pneumoniae-infected hamsters. Arai S; Gohara Y; Akashi A; Kuwano K; Nishimoto M; Yano T; Oizumi K; Takeda K; Yamaguchi T Antimicrob Agents Chemother; 1993 Feb; 37(2):287-92. PubMed ID: 8383942 [TBL] [Abstract][Full Text] [Related]
6. Susceptibilities of Mycoplasma pneumoniae, Mycoplasma hominis, and Ureaplasma urealyticum to a new quinolone, trovafloxacin (CP-99,219). Kenny GE; Cartwright FD Antimicrob Agents Chemother; 1996 Apr; 40(4):1048-9. PubMed ID: 8849228 [TBL] [Abstract][Full Text] [Related]
7. In-vitro and in-vivo activity of a new quinolone AM-1155 against Mycoplasma pneumoniae. Ishida K; Kaku M; Irifune K; Mizukane R; Takemura H; Yoshida R; Tanaka H; Usui T; Tomono K; Suyama N J Antimicrob Chemother; 1994 Dec; 34(6):875-83. PubMed ID: 7730231 [TBL] [Abstract][Full Text] [Related]
8. Susceptibility of Mycoplasma pneumoniae to several new quinolones, tetracycline, and erythromycin. Kenny GE; Cartwright FD Antimicrob Agents Chemother; 1991 Mar; 35(3):587-9. PubMed ID: 1903913 [TBL] [Abstract][Full Text] [Related]
9. Susceptibilities of Mycoplasma hominis, Mycoplasma pneumoniae, and Ureaplasma urealyticum to a new quinolone, OPC 17116. Kenny GE; Cartwright FD Antimicrob Agents Chemother; 1993 Aug; 37(8):1726-7. PubMed ID: 8215294 [TBL] [Abstract][Full Text] [Related]
18. [The use of Maxaquin (lomefloxacin hydrochloride) in the treatment of nonspecific inflammatory diseases and in the prevention of surgical interventions in urology]. Derevianko II; Lopatkin NA; Khodyreva LA; Kondrat'eva EM Urol Nefrol (Mosk); 1998; (5):14-8. PubMed ID: 9820038 [No Abstract] [Full Text] [Related]